Abstract: An integrative literature review was conducted to synthesize available publications regarding the potential use of serological tests in leprosy programs. We searched the databases Literatura Latino-Americana e do Caribe em Ciências da Saúde, Índice Bibliográfico Espanhol em Ciências da Saúde, Acervo da Biblioteca da Organização Pan-Americana da Saúde, Medical Literature Analysis and Retrieval System Online, Hanseníase, National Library of Medicine, Scopus, Ovid, Cinahl, and Web of Science for articles investigating the use of serological tests for antibodies against phenolic glycolipid-I (PGL-I), ML0405, ML2331, leprosy IDRI diagnostic-1 (LID-1), and natural disaccharide octyl-leprosy IDRI diagnostic-1 (NDO-LID). From an initial p...
A sorologia para detecção de anticorpos da classe IgM contra o PGL-I, antígeno específico do M. lepr...
The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups w...
A cross-sectional clinical trial in which the serum anti-phenolic glycolipid (anti-PGL-1) antibodies...
An integrative literature review was conducted to synthesize available publications regarding the po...
BACKGROUND There is a lack of straightforward tests for field application and known biomarkers for ...
The authors studied 70 leprosy patients and 20 normal individuals, comparing the traditional sera co...
Leprosy is a chronic infectious condition caused by Mycobacterium leprae(M. leprae). It is endemic i...
Texto completo: acesso restrito. p. 1400-1408Leprosy is a chronic and debilitating human disease cau...
Copyright © 2014 Avnish Kumar et al. This is an open access article distributed under the Creative C...
Globally more than 200,000 people develop leprosy every year and 2-3 million people live with lepr...
The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups w...
Despite elimination efforts, the number of Mycobacterium leprae (M. leprae) infected individuals who...
Leprosy is an infectious disease that affects peripheral nerves and can lead to severe lifelong disa...
Leprosy is an infectious disease caused by Mycobacterium leprae and mainly affects skin, peripheral ...
Leprosy diagnosis is mainly based on clinical evaluation, although this approach is difficult, espec...
A sorologia para detecção de anticorpos da classe IgM contra o PGL-I, antígeno específico do M. lepr...
The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups w...
A cross-sectional clinical trial in which the serum anti-phenolic glycolipid (anti-PGL-1) antibodies...
An integrative literature review was conducted to synthesize available publications regarding the po...
BACKGROUND There is a lack of straightforward tests for field application and known biomarkers for ...
The authors studied 70 leprosy patients and 20 normal individuals, comparing the traditional sera co...
Leprosy is a chronic infectious condition caused by Mycobacterium leprae(M. leprae). It is endemic i...
Texto completo: acesso restrito. p. 1400-1408Leprosy is a chronic and debilitating human disease cau...
Copyright © 2014 Avnish Kumar et al. This is an open access article distributed under the Creative C...
Globally more than 200,000 people develop leprosy every year and 2-3 million people live with lepr...
The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups w...
Despite elimination efforts, the number of Mycobacterium leprae (M. leprae) infected individuals who...
Leprosy is an infectious disease that affects peripheral nerves and can lead to severe lifelong disa...
Leprosy is an infectious disease caused by Mycobacterium leprae and mainly affects skin, peripheral ...
Leprosy diagnosis is mainly based on clinical evaluation, although this approach is difficult, espec...
A sorologia para detecção de anticorpos da classe IgM contra o PGL-I, antígeno específico do M. lepr...
The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups w...
A cross-sectional clinical trial in which the serum anti-phenolic glycolipid (anti-PGL-1) antibodies...